Literature DB >> 12529421

Interrelationships of interleukin-8 with interleukin-1beta and neutrophils in vaginal fluid of healthy and bacterial vaginosis positive women.

Sabina Cauci1, Secondo Guaschino, Domenico De Aloysio, Silvia Driussi, Davide De Santo, Paola Penacchioni, Franco Quadrifoglio.   

Abstract

Vaginal innate immunity in response to microbial perturbation is still poorly understood and could be crucial for protection from adverse outcomes. We investigated the relationship between interleukin (IL)-8, IL-1beta and neutrophils in vaginal fluid obtained from 60 healthy women and 51 women who were bacterial vaginosis (BV) positive. Concentrations of IL-8 and IL-1beta were highly correlated with counts of neutrophils in vaginal fluid of the entire population examined (111 subjects). Vaginal IL-1beta concentrations were significantly higher (P < 0.001) in BV positive women. There was no significant difference in IL-8 levels or number of neutrophils between healthy controls and BV positive women. None of the healthy controls with high neutrophil counts (> or =75th percentile, 14 average count per field) had high concentrations of IL-1beta (> or =75th percentile, 220 pg/ml), whereas 84% of BV positive women with high neutrophil counts had high IL-1beta concentrations (P < 0.001). On the contrary, no difference in the percentage of subjects with elevated concentrations of IL-8 (> or =75th percentile, 2842 pg/ml) was found between healthy and BV positive women with high numbers of neutrophils (55.5% of healthy versus 53% of BV positive women). Our findings show that BV causes a large increase in IL-1beta concentrations which is not paralleled by an increase in IL-8 concentrations in vaginal fluid, suggesting that BV-associated factors more specifically dampen IL-8 rather than IL-1beta. The lack of an increase in IL-8 may explain the absence of an increase in neutrophil numbers in most women exposed to abnormal vaginal colonization (BV).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12529421     DOI: 10.1093/molehr/gag003

Source DB:  PubMed          Journal:  Mol Hum Reprod        ISSN: 1360-9947            Impact factor:   4.025


  55 in total

Review 1.  Treatment of abnormal vaginal flora in early pregnancy with clindamycin for the prevention of spontaneous preterm birth: a systematic review and metaanalysis.

Authors:  Ronald F Lamont; Chia-Ling Nhan-Chang; Jack D Sobel; Kimberly Workowski; Agustin Conde-Agudelo; Roberto Romero
Journal:  Am J Obstet Gynecol       Date:  2011-04-02       Impact factor: 8.661

2.  Cervicovaginal levels of lactoferrin, secretory leukocyte protease inhibitor, and RANTES and the effects of coexisting vaginoses in human immunodeficiency virus (HIV)-seronegative women with a high risk of heterosexual acquisition of HIV infection.

Authors:  Richard M Novak; Betty A Donoval; Parrie J Graham; Lucy A Boksa; Gregory Spear; Ronald C Hershow; Hua Yun Chen; Alan Landay
Journal:  Clin Vaccine Immunol       Date:  2007-08-01

Review 3.  Taking probiotics during pregnancy. Are they useful therapy for mothers and newborns?

Authors:  Gregor Reid; Pirkka Kirjaivanen
Journal:  Can Fam Physician       Date:  2005-11       Impact factor: 3.275

4.  Anti-human immunodeficiency virus type 1 microbicide cellulose acetate 1,2-benzenedicarboxylate in a human in vitro model of vaginal inflammation.

Authors:  R N Fichorova; F Zhou; V Ratnam; V Atanassova; S Jiang; N Strick; A R Neurath
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

5.  Myeloperoxidase selectively binds and selectively kills microbes.

Authors:  Robert C Allen; Jackson T Stephens
Journal:  Infect Immun       Date:  2010-10-25       Impact factor: 3.441

6.  Racial differences in cervical cytokine concentrations between pregnant women with and without bacterial vaginosis.

Authors:  Kelli K Ryckman; Scott M Williams; Marijane A Krohn; Hyagriv N Simhan
Journal:  J Reprod Immunol       Date:  2008-03-11       Impact factor: 4.054

Review 7.  Exploring a road map to counter misconceptions about the cervicovaginal microbiome and disease.

Authors:  Jean M Macklaim; Craig R Cohen; Gilbert Donders; Gregory B Gloor; Janet E Hill; Groesbeck P Parham; Jacques Ravel; Gregory Spear; Janneke van de Wijgert; Gregor Reid
Journal:  Reprod Sci       Date:  2012-05-21       Impact factor: 3.060

8.  Safety analysis of the diaphragm in combination with lubricant or acidifying microbicide gels: effects on markers of inflammation and innate immunity in cervicovaginal fluid.

Authors:  Deborah J Anderson; D'Nyce L Williams; Susan A Ballagh; Kurt Barnhart; Mitchell D Creinin; Daniel R Newman; Frederick P Bowman; Joseph A Politch; Ann C Duerr; Denise J Jamieson
Journal:  Am J Reprod Immunol       Date:  2009-02       Impact factor: 3.886

9.  Changes in the vaginal microenvironment with metronidazole treatment for bacterial vaginosis in early pregnancy.

Authors:  Caroline Mitchell; Jennifer Balkus; Kathy Agnew; Richard Lawler; Jane Hitti
Journal:  J Womens Health (Larchmt)       Date:  2009-11       Impact factor: 2.681

10.  Matrix Metalloproteinases Expressed in Response to Bacterial Vaginosis Disrupt the Endocervical Epithelium, Increasing Transmigration of HIV.

Authors:  Michelle D Cherne; Amy L Cole; Lisa Newberry; Mary Schmidt-Owens; Michael Deichen; Alexander M Cole
Journal:  Infect Immun       Date:  2020-03-23       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.